This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Scripps Research Institute. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Innovations by Jonathan W Lockner
Introduction
Jonathan W Lockner is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmacology, particularly in cancer treatment. With a total of four patents to his name, Lockner's work focuses on innovative compounds that can induce gene expression in macrophages.
Latest Patents
Lockner's latest patents include the development of imidazolinopyrimidinone compounds that have shown activity in inducing TRAIL gene expression. This discovery is crucial for creating methods to treat various cancers. The compounds are designed to be administered in effective amounts, showcasing Lockner's commitment to advancing cancer therapies.
Career Highlights
Lockner is affiliated with The Scripps Research Institute, where he conducts his research and development. His work has been instrumental in exploring new avenues for cancer treatment, making him a valuable asset in the scientific community.
Collaborations
Lockner has collaborated with esteemed colleagues such as Kim D Janda and Nicholas T Jacob. These partnerships have further enhanced his research efforts and contributed to the success of his innovative projects.
Conclusion
Jonathan W Lockner's contributions to pharmacology and cancer treatment through his patents highlight his role as a leading inventor in the field. His ongoing research continues to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile